Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
| blood testing for antibodies or antigens in context | Obtain the exposure-specific serology requested by infectious diseases. | Plan | Diagnostic procedures and specimen handling | |
equivocal serology | antibody or antigen result falls into the assay's indeterminate zone | Equivocal serology was recorded with the assay-specific cutoff information. | Objective | Molecular testing, serology and culture findings |
absolute CD4 count | number of CD4-positive T cells in a defined volume of blood | The absolute CD4 count was recorded separately from the CD4 percentage. | Objective | Molecular testing, serology and culture findings |
acid-fast smear | microscopic examination for organisms retaining an acid-fast stain | Acid-fast smear was reported separately from the organism-specific molecular test. | Objective | Molecular testing, serology and culture findings |
acute-phase serum | blood serum collected early in the course of an illness | Acute-phase serum was labeled with the day of illness. | Objective | Molecular testing, serology and culture findings |
aerobic culture | culture performed under conditions permitting aerobic growth | Aerobic culture was reported alongside the Gram stain from the same specimen. | Objective | Molecular testing, serology and culture findings |
amplification inhibition | sample contains substances that interfere with the amplification reaction | Amplification inhibition was reported when the internal control failed. | Objective | Molecular testing, serology and culture findings |
anaerobic culture | culture performed under conditions permitting growth of anaerobes | Anaerobic culture was obtained from the specified deep specimen. | Objective | Molecular testing, serology and culture findings |
antibody avidity | measure of the overall binding strength of an antibody population | Antibody avidity was reported with the assay-specific interpretation. | Objective | Molecular testing, serology and culture findings |
beta-D-glucan | fungal cell-wall component measured by a nonspecies-specific assay | Beta-D-glucan was reported with the laboratory cutoff and exposure history. | Objective | Molecular testing, serology and culture findings |
broad pauciseptate hyphae | broad fungal filaments with few visible cross-walls | Broad pauciseptate hyphae were seen in the tissue section with organism identification pending. | Objective | Molecular testing, serology and culture findings |
budding yeast | yeast forms producing a small daughter cell | Budding yeast were seen in the submitted specimen. | Objective | Molecular testing, serology and culture findings |
carbapenemase detection | test identifies a carbapenem-hydrolyzing enzyme or its genetic determinant | Carbapenemase detection was reported with the method and organism. | Objective | Molecular testing, serology and culture findings |
CD4 percentage | proportion of lymphocytes identified as CD4-positive T cells | The CD4 percentage was interpreted alongside the absolute CD4 count. | Objective | Molecular testing, serology and culture findings |
colony morphology | visible appearance of microbial colonies on culture media | Colony morphology was described before species identification. | Objective | Molecular testing, serology and culture findings |
convalescent serum | blood serum obtained later to compare with an earlier illness sample | Convalescent serum was tested alongside the acute specimen. | Objective | Molecular testing, serology and culture findings |
cryptococcal antigen | test for a capsular antigen from Cryptococcus | The cryptococcal antigen was reported with the specimen type and titer, when provided. | Objective | Molecular testing, serology and culture findings |
epidemiological cutoff value | threshold separating the wild-type distribution from isolates with unusual susceptibility | Epidemiological cutoff value was identified separately from a clinical breakpoint. | Objective | Molecular testing, serology and culture findings |
extended-spectrum beta-lactamase | enzyme capable of hydrolyzing a range of extended-spectrum beta-lactams | Extended-spectrum beta-lactamase was identified in the microbiology comment on the isolate. | Objective | Molecular testing, serology and culture findings |
fungal culture | growth-based testing for fungi from a submitted specimen | Fungal culture was labeled with the tissue source and collection date. | Objective | Molecular testing, serology and culture findings |
galactomannan index | assay index measuring a fungal cell-wall antigen in the submitted specimen | The galactomannan index was documented with the assay and specimen source. | Objective | Molecular testing, serology and culture findings |
Gram-negative rods | rod-shaped bacteria staining Gram negative | Gram-negative rods were reported before species identification. | Objective | Molecular testing, serology and culture findings |
Gram-positive cocci in chains | round Gram-positive bacteria arranged in chains | Gram-positive cocci in chains were reported on the preliminary stain. | Objective | Molecular testing, serology and culture findings |
Gram-positive cocci in clusters | round bacteria staining Gram positive and arranged in clusters | Gram-positive cocci in clusters were reported from the first positive blood culture bottle. | Objective | Molecular testing, serology and culture findings |
Gram-variable organisms | microbes in the specimen do not show a uniform Gram reaction | Gram-variable organisms were described in the preliminary stain report. | Objective | Molecular testing, serology and culture findings |